CytoMed Therapeutics Ltd (GDTC)
2.04
-0.03
(-1.45%)
USD |
NASDAQ |
Jun 25, 16:00
CytoMed Therapeutics EPS Diluted (Annual): -0.2904 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -0.2904 |
December 31, 2022 | -0.2077 |
Date | Value |
---|---|
December 31, 2021 | -0.1396 |
December 31, 2020 | -0.1283 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-0.2904
Minimum
2023
-0.1283
Maximum
2020
-0.1915
Average
-0.1736
Median
EPS Diluted (Annual) Benchmarks
Haw Par Corp Ltd | 0.7281 |
WAVE Life Sciences Ltd | -0.54 |
ASLAN Pharmaceuticals Ltd | -2.75 |
EUDA Health Holdings Ltd | -0.44 |
Mobile-health Network Solutions | -0.0945 |